An observational follow-up study of women who become pregnant while participating in a certolizumab pegol (CZP) clinical study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnancy

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Drug registry

  Other
• Data sources (types), other:
  Prospective patient-based data collection

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown